跳至主要内容
临床试验/ACTRN12620000855921
ACTRN12620000855921暂停4 期

Investigating the efficacy of early vs. late primaquine treatment for children with uncomplicated malaria due to infection with either Plasmodium vivax or Plasmodium falciparum

The University of Western Australia0 个研究点目标入组 220 人开始时间: 2020年8月27日最近更新:
适应症

试验速览

阶段
4 期
状态
暂停
入组人数
220

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Prevention
盲法
Open (masking not used)

入排标准

年龄范围
6 Months 至 12 Years(—)
性别
All

入选标准

  • i) Children aged 0.5 to 12 years
  • ii) Axillary temperature >37.5 degrees Celcius (or self-reported fever during previous 24 hours)
  • iii) Positive for malaria by on-site microscopy, or rapid diagnostic test, or polymerase chain reaction
  • iv) Have not received a study intervention in the previous 4 weeks
  • v) They have no significant co-morbidity
  • vi) they can attend follow-up assessments over the full duration of the study.

排除标准

  • i) Clinical signs or symptoms consistent with severe malaria
  • ii) History of allergy to artemether-lumefantrine or primaquine
  • iii) A proven history of G6PD deficiency
  • iv) Severe malnutrition
  • v) Haemoglobin <50 g/

研究者

相似试验